Mr. Gorevic is president and chief executive officer of Teladoc, Inc. and a member of our board of directors since June 2009.
Mr. Gorevic is responsible for building a stronger Teladoc for the future and driving growth and innovation that leads to outperformance for our members, clients, partners, employees and shareholders. Under his leadership, Teladoc achieved a compound annual growth rate (CAGR) in revenue of almost 100 percent from 2013 through 2015 and, in July 2015, priced its initial public offering.
Prior to joining Teladoc, Mr. Gorevic served in various management roles at WellPoint, Inc. (now Anthem, Inc.), including president of Empire BlueCross BlueShield and senior vice president and chief sales and product officer. From 2002 to 2005, Mr. Gorevic was a member of Empire BlueCross BlueShield’s leadership team, as chief sales and marketing officer. From July 2000 to December 2001, Mr. Gorevic served as chief executive officer of Gemfinity, an electronic marketplace and purchasing aggregator that he founded. From July 1999 to July 2000, he served as general manager of business messaging at Mail.com, Inc., a provider of Internet messaging services, and from April 1998 to June 1999, he served as Mail.com’s vice president of operations.
Earlier in his career, Mr. Gorevic worked at Oxford Health Plans, Inc. and held a variety of positions in marketing, medical management and operations as well as director of service strategy. Mr. Gorevic earned a Bachelor of Arts in international relations from the University of Pennsylvania.
Mr. Snow became a member of our board of directors in February 2014 and later was named chairman of our board in December
Since February 2014, Mr. Snow has served as chairman and chief executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to doctor and hospital organizations entering risk-based reimbursement arrangements with insurers. Until April 2012, Mr. Snow was chairman and chief executive officer of Medco Health Solutions, Inc., a leading pharmacy benefit manager. His current board service includes CareCentrix (since 2014) and Pitney Bowes, Inc. (since 2006). He formerly served as a director of Medco Health Solutions, Inc.
In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies including WellChoice (Empire Blue Cross Blue Shield) and Oxford Health Plans. Mr. Snow earned a Bachelor of Science in economics from Bates College and a master’s degree in Health Care Administration from Duke University.
Ms. Darling became a member of our board of directors in June 2016.
She is currently a strategic advisor in health benefits & policy in Washington DC. She previously served as interim president & CEO of the National Quality Forum (NQF), as well as a past president and chief executive officer of the National Business Group on Health (NBGH). Ms. Darling serves on the Committee on Performance Measurement of the National Committee for Quality Assurance (NCQA) and the Medical Advisory Panel of the Blue Cross Blue Shield Association’s Center for Clinical Effectiveness. Previously in her career, she directed the purchasing of health and disability benefits at Xerox Corporation for 55,000 U.S. employees. She also served as a principal at William W. Mercer and a practice leader at Watson Wyatt.
Ms. Darling was named one of the “60 Most Powerful People in Healthcare” by Becker’s Hospital Review in 2016 and named one of Modern Healthcare’s “100 Most Influential People in Healthcare” from 2003 to 2007 and 2010 to 2013. Her current board service includes the Advisory Board for the Peter G. Peterson Foundation and the Board of the Reagan Udall Foundation for the FDA. She directed studies at the Institute of Medicine and was LA on Health Policy for former U.S. Sen. David Durenberger, Senate Finance Committee. Ms. Darling holds a master’s degree in Demography and Sociology and a Bachelor of Science in history and English, cum laude, from the University of Memphis.
U.S. Sen. William Frist became a member of our board of directors in September 2014.
Since 2007, Sen. Frist has served as a partner in Cressey & Company, a private investment firm focused exclusively on growing emerging health care businesses. He served as U.S. Senator for Tennessee from 1995 to 2007 and was majority leader of the Senate from 2003 to 2007, participating in the debate and development of major public policy issues and health legislation. Prior to the Senate, Sen. Frist spent 20 years in clinical medicine, completing surgical training at Harvard’s Massachusetts General Hospital and at Stanford; he subsequently founded the Vanderbilt Multi-Organ Transplant Center. Sen. Frist serves as an adjunct professor of cardiac surgery at Vanderbilt University and clinical professor of surgery at Meharry Medical College.
Sen. Frist currently serves as a director of the publicly held companies Select Medical and AECOM. In addition, he serves as a board member for several of Cressey & Company’s privately-held portfolio companies. He previously served as a director of URS Corporation from November 2009 to 2014, and on the board of Third National Bank from 1990 to 1994.
Sen. Frist serves on the boards of several other organizations, including the Center for Strategic and International Studies, Partnership for a Healthier America, Hope Through Healing Hands, the Kaiser Family Foundation, the Robert Wood Johnson Foundation, the Nashville Health Center Care Council and the Harvard Medical School Board of Fellows.
He is a senior fellow at the Bipartisan Policy Center, where he is co-leader of the Health Project. Sen. Frist earned a Bachelor of Arts from Princeton University and M.D. from Harvard Medical School.
Mr. Goldstein became a member of our board of directors in February 2015.
Mr. Goldstein is the retired chairman and chief executive officer of Toys “R” Us, Inc. He joined Toys “R” Us in 1983 as chief financial officer and served in various executive level positions in the course of his 18 year tenure there.
Since 2015, Mr. Goldstein has served as director and member of the audit committee and corporate strategy committee of BioScrip, Inc. He was formerly the lead director for Medco Health Solutions, Inc., one of the largest pharmacy benefit managers and mail order pharmacy operators in the United States, which was acquired by Express Scripts Holdings. He is also a former partner at Ernst & Young LLP and is a director of numerous private companies and not-for-profit charitable organizations. He is a certified public accountant and graduated magna cum laude from Queens College with a Bachelor of Science in economics.
Mr. Mawhinney became a member of our board of directors in September 2014.
He is currently a general partner of Icon Ventures, a technology venture capital firm, having joined the firm in 2003. Before joining Icon, Mr. Mawhinney was with Canaan Partners, an early stage venture capital firm with $2 billion under management, from 2001 to 2003. As an entrepreneur, Mr. Mawhinney co-founded and spent five years as president and chief operating officer of North Systems, a venture-backed software company. Prior to his time with North Systems, he developed his skills as a technology investor and entrepreneur working as a senior associate at Summer Partners.
Mr. Mawhinney is on the boards of directors of, or otherwise actively involved with, Awarepoint, Bill.com, Huddle, Ionic Security, KIXEYE, Reputation.com, Xambala, Yodle, Area1 Securit, Synack and Zephyr Health. Mr. Mawhinney graduated with honors, earning a Bachelor of Arts from Harvard University and received his Master of Business Administration from the Stanford University Graduate School of Business.
Mr. McAndrews became a member of our board of directors in September 2017.
The former chief executive officer, president and chairman of Pandora Media, he has a depth of knowledge in data, analytics and artificial intelligence (AI). Mr. McAndrews currently sits on the board of Amplero, a recognized leader in leveraging AI marketing to maximize customer lifetime value and loyalty, and also served as president and CEO of aQuantive, Inc., a top ten global digital marketing services and adtech company, that was acquired by Microsoft.
Mr. McAndrews has spent a significant portion of his career driving growth and innovation for leading advertising and content companies. For nearly a decade he held positions of increasing responsibility at ABC, Inc., leaving as executive vice president and general manager of ABC Sports.
He was named one of "The Power 100" by Billboard Magazine in 2016 and 2015, as well as one of the 30 most influential executives in the advertising, marketing and media world by Adweek in 2008. Mr. McAndrews is chairman of the technology and innovation committees of The New York Times, chairman of the board of Grubhub, and also sits on the boards of The Wine Group and The United Way of King County. He holds an M.B.A. from Stanford Graduate School of Business and a Bachelor of Arts from Harvard College.
Mr. McKinley became a member of our board of directors in November 2009.
Mr. McKinley, who has more than 35 years of investment experience, is a general partner and the west coast representative for Cardinal Partners, a venture capital firm focused exclusively on healthcare investing. Prior to joining Cardinal, Mr. McKinley was the co-founder and co-managing partner of Partech International. Mr. McKinley currently serves on the board of directors of lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians and patients.
In addition, Mr. McKinley is the founding chief executive officer and director of Cardinal Analytx, a software start-up spun out of Stanford University that was created to identify and target high-cost patients for early medical interventions. Mr. McKinley earned Bachelor of Arts in economics from Harvard University, a Master of Science in accounting from New York University and a Master of Business Administration from the Stanford University Graduate School of Business.
Mr. Multani became a member of our board of directors in 2008.
Mr. Multani is a managing director of Trident Capital, where he leads the firm’s healthcare IT practice, and is a co-founder and managing director of TC Growth, a growth-equity firm spun out of Trident Capital in 2015. Prior to joining Trident in 2002, Mr. Multani was an associate at McCown De Leeuw, a private equity firm specializing in leveraged buy-outs, where he focused on investing in the health and fitness industries.
He started his career as an analyst at Morgan Stanley & Co. in the media and telecommunications area of the mergers & acquisitions group. Mr. Multani currently sits on the board of directors of Imagine Health, Arrohealth and HealthMEDX. His past directorships and observer-ships include Acclaris, Resolution Health and Profex. Mr. Multani earned a Bachelor of Science in economics from Wharton School of Business and a Bachelor of Applied Science in systems engineering from the Moore School of Engineering at the University of Pennsylvania. He earned his Master of Business Administration from the Stanford University Graduate School of Business.
Mr. Paulus became a member of our board of directors in February 2017.
From 2009 to 2014, Mr. Paulus was President and CEO of Allina Health, one of the nation’s largest not-for-profit integrated delivery systems consisting of nearly 1,500 employed physicians, 13 acute care hospitals, a freestanding emergency department, and more than 100 ambulatory care clinics. Prior to his appointment as CEO, he served as president and Chief Operating Officer of Allina Health. Before joining Allina, Mr. Paulus was the President and CEO of Atrius Health System, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He also served as the Chief Operating Officer of Boston-based Partners Community Health Care, a teaching affiliate of Harvard Medical School that includes Massachusetts General Hospital and Brigham and Women’s Hospital.
Mr. Paulus is an executive advisor at Water Street Healthcare Partners, a private investment firm, and currently serves on the board of Health Grades. Mr. Paulus received his Masters of Healthcare Administration and Management from the University of Minnesota, and a Bachelor of Arts in biology from Augustana College.
Mr. Shedlarz became a member of our board in September 2016.
He is the former vice chairman, executive vice president and chief financial officer of Pfizer, Inc., having had worldwide responsibility for the company’s former Medical Technology Group. During his 31-year tenure at Pfizer, Mr. Shedlarz played a key role in shaping the strategic direction that drove the company’s impressive growth and helped establish it as an industry leader and innovator. Among his senior leadership roles were that of executive vice president beginning in 1999, and then vice chairman in 2005, serving until his retirement in 2007.
In addition to the Teladoc board, Mr. Shedlarz also sits on the boards of The Hershey Company, Pitney Bowes Inc. and the Teacher Insurance and Annuity Association. He holds a Master of Business Administration in finance and accounting from New York University, Leonard N. Stern School of Business, and a Bachelor of Science in economics and mathematics from Oakland/Michigan State University.